Showing results (81-90 of 179) with videos related to

Sort By:
Pageof 18
Cancer|July 29, 2010
Expression of p16(INK4A) but not hypoxia markers or poly adenosine diphosphate-ribose polymerase is associated with improved survival in patients with pancreatic adenocarcinomaDaniel T Chang, Christopher H Chapman, Jeffrey A Norton, et al.
JCO Precision Oncology|February 9, 2022
Pathogenic Variants in Less Familiar Cancer Susceptibility Genes: What Happens After Genetic Testing?Evan T Hall, Divya Parikh, Jennifer L Caswell-Jin, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|May 28, 2011
HER2 expression in gastric and gastroesophageal junction adenocarcinoma in a US population: clinicopathologic analysis with proposed approach to HER2 assessmentPamela L Kunz, Amirkaveh Mojtahed, George A Fisher, et al.
Annals of Surgery|May 25, 2007
CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancerJeffrey A Norton, Christine M Ham, Jacques Van Dam, et al.
International Journal of Radiation Oncology, Biology, Physics|December 31, 2002
Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil, and weekly CPT-11, followed by surgery for ultrasound-staged T3 rectal cancerVivek K Mehta, Cheryl Cho, James M Ford, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 19, 2018
From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor SequencingJulia R Trosman, Christine B Weldon, William J Gradishar, et al.
International Journal of Radiation Oncology, Biology, Physics|January 9, 2010
18Fluorodeoxyglucose PET is prognostic of progression-free and overall survival in locally advanced pancreas cancer treated with stereotactic radiotherapyDevin Schellenberg, Andy Quon, A Yuriko Minn, et al.
The American Journal of Surgical Pathology|April 9, 2008
Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implicationsWilliam M Rogers, Erika Dobo, Jeffrey A Norton, et al.
NPJ Precision Oncology|February 3, 2025
MDM2 inhibition is associated with the emergence of TP53-altered clonal hematopoiesisVishesh Khanna, Gohar Eslami, Rochelle Reyes, et al.
Cancer Genetics|August 15, 2015
The importance of analysis of long-range rearrangement of BRCA1 and BRCA2 in genetic diagnosis of familial breast cancerAva Kwong, Jiawei Chen, Vivian Y Shin, et al.
Pageof 18